Raffaele Longo

Bevacizumab and platinum-based combinations for recurrent ovarian cancer: a randomised, open-label, phase 3 trial

Jacobus Pfisterer, Catherine Shannon, Klaus Baumann et al. · The Lancet Oncology · 2020 · 162 citations

Medicine, Gynecology, Oncology +14

Rhodotorula mucilaginosa outbreak in neonatal intensive care unit: microbiological features, clinical presentation, and analysis of related variables

Roberto Perniola, Maria Letizia Faneschi, Esther Manso et al. · European Journal of Clinical Microbiology & Infectious Diseases · 2006 · 43 citations

Medicine, Microbiology, Pediatrics +17

Trastuzumab in combination with gemcitabine and vinorelbine as second-line therapy for HER-2/neu overexpressing metastatic breast cancer

Alessandro Morabito, Raffaele Longo, Domenico Gattuso et al. · Oncology Reports · 2006 · 34 citations · Full text

Medicine, Oncology, Pharmacology +14

Unusual Sites of Metastatic Malignancy

Raffaele Longo, David Mocini, Massimo Santini et al. · Journal of Clinical Oncology · 2004 · 29 citations · Full text

Medicine, Oncology, Pathology +14

Long-Term Follow-Up of a Pilot Phase II Study with Neoadjuvant Epidoxorubicin, Etoposide and Cisplatin in Gastric Cancer

Carlo Barone, Alessandra Cassano, Carmelo Pozzo et al. · Oncology · 2004 · 28 citations

Medicine, Oncology, Pharmacology +13